We hypothesize that this positive relationship between pAMPK and pSMAD2/SMAD4 may be involved in an important, as-yet-unidentified mechanism that is critical to the inhibition of ccRCC. The gene discussed is SMAD4; the disease is nonpapillary renal cell carcinoma.